Survival for ethmoid sinus adenocarcinoma in European populations

Acta Oncologica

Volumn 48, Issue 7, 2009, Pages 992-998

  Gatta, Gemma ^a   Bimbi, Gabriella ^a   Ciccolallo, Laura ^a   Zigon, Giulia ^a   Cantu', Giulio ^a   The Eurocare Working Group, ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b Austria: W Oberaigner (Tyrol Cancer Registry)   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER REGISTRY; CANCER SURVIVAL; CONTROLLED STUDY; ETHMOID SINUS ADENOCARCINOMA; EUROPE; FEMALE; GEOGRAPHIC PATHOLOGY; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARANASAL SINUS CARCINOMA; POPULATION RESEARCH; PRIORITY JOURNAL;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE OF ONSET; AGED; AGED, 80 AND OVER; EARLY DETECTION OF CANCER; ETHMOID SINUS; EUROPE; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; OCCUPATIONAL DISEASES; PARANASAL SINUS NEOPLASMS; RARE DISEASES; REGISTRIES; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 70350075992     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860902874755     Document Type: Article

References (25)

1. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence in five continents, vol.VIII. IARC Scientific Publications No. 155. Lyon: IARC; 2002.
2. Berrino F, Capocaccia R, Coleman MP, Estève J, Gatta G, Hakulinen T, et al. Survival of cancer patients in Europe: The EUROCARE 3 study. Ann Oncol 2003;14(Suppl 5): 1-155.
3. World Health Organisation. International classification of diseases. 9th ed. Geneva: 1975.
4. World Health Organisation. International statistical classifi- cation of diseases and related health problems. 10th revision, Vols 1-3. 1992-1994. 3rd ed. Geneva: 1994.
5. European Network of Cancer Registries. Eurocim version 4.0. European incidence database V2.3, 730 entity dictionary Lyon 2001.
6. Barnes L. Intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Am J Surg Pathol 1986;10:192-202.
7. Capocaccia R, Gatta G, Roazzi P, Carrani E, Santaquilani M, De Angelis R, et al. The EUROCARE-3 database: Methodology of data collection, standardisation, quality control and statistical analysis. Ann Oncol 2003;14 (Suppl 5):14-27.
8. Jiong L, Berrino F, Coebergh JW and the EUROCARE Working Group. Variation in survival for adults with nasopharyngeal cancer in Europe, 1978-1989. Eur J Cancer 1998;34:2162-2166 (Pubitemid 29036881)
9. Berrino F, Gatta G. and EUROCARE Working Group. Variation in survival of patients with head and neck cancer in Europe by the site of origin of the tumours. Eur J Cancer 1998;34:2154-2161.
10. World Health Organisation. International classification of diseases for oncology (ICD-O). 2nd ed. Geneva: 1990.
11. Berg JM. Morphological classification of human cancer. In: Schottenfeld D, Fraumeni JF editor. Cancer epidemiology and prevention, 2nd ed. New York: OUP; 1996. p 28-44.
12. Coleman MP, Gatta G, Verdecchia A, Estève J, Sant M, Storm H, et al. EUROCARE-3 summary: Cancer survival in Europe at the end of the 20th century. Ann Oncol 2003; 14(Suppl 5):128-149.
13. Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982;38:933-942.
14. Micheli A, Baili P, Quinn M, Mugno E, Capocaccia R, Grosclaude P. Life expectancy and cancer survival in the EUROCARE-3 cancer registry areas. Ann Oncol 2003; 14(Suppl 5):28-40.
15. Hakulinen T, Tenkanen L. Regression analysis of relative survival rates. Applied Stat 1987;19:197-207.
16. Surveillance Research Program, National Cancer Institute SEER*Stat software (www.seer.cancer.govseerstat) version 5.2.2.
17. StataCorp. 2001. Stata Statistical Software: Release 7.0. College Station, TX: Stata Corporation.
18. Stoll D, Bebear JP, Truilhe Y, Darrouzet V, David N. Ethmoid adenocarcinoma: Retrospective study of 76 patients. Rev Laryngol Otol Rhinol (Bord) 2001;122:21-29.
19. Jiang G-L, Morrison WH, Garden AS, Geara F, Callender D, Goepfert H, et al. Ethmoid sinus carcinoma: Natural history and treatment results. Radiother Oncol 1998;49: 21-27
20. Dulguerov P, Jacobsen MS, Allal AS, Lehmann W, Calcaterra T, et al. Nasal and paranasal sinus carcinoma: Are we making progress? Cancer 2001;92:3012-3029.
21. Grau C, Jakobsen H, Harbo G, Svane-Knudsen V, Wedervang K, Larsen SK, et al. Sino-nasal cancer in Denmark 1982-1991. A nationwide survey. Acta Oncol 2001;40: 19-23.
22. Bhattacharyya N. Factors predicting survival for cancer of the ethmoid sinus. Am J Rhinol 2002;16:281-286. (Pubitemid 35314860)
23. Weymuller EA, Reardon EJ, Nash D. A comparison of treatment modalities in carcinoma of maxillary antrum. Arch Otorhinolaryngol 1980;106:625-629.
24. Engzell U, Englund A, Westerholm P. Nasal cancer associated with occupational exposure to organic dust. Acta Otolaryngol 1978;86:437-442.
25. Cecchi F, Buiatti E, Kriebel D. Adenocarcinoma of the nose and paranasal sinuses in shoemakers and woodworkers in the province of Florence, Italy. Br J Ind Med 1980;37:222-225.